Nilutamide

In the US, Nilutamide (nilutamide systemic) is a member of the following drug classes: antiandrogens, hormones/antineoplastics and is used to treat Prostate Cancer.

US matches:

• Nilutamide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L02BB02

CAS registry number (Chemical Abstracts Service)

0063612-50-0

Chemical Formula

C12-H10-F3-N3-O4

Molecular Weight

317

Therapeutic Categories

Antineoplastic agent

Antiandrogen

Chemical Name

2,4-Imidazolidinedione, 5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-

Foreign Names

• Nilutamidum (Latin)
• Nilutamid (German)
• Nilutamide (French)
• Nilutamida (Spanish)

Generic Names

• Nilutamide (OS: BAN, DCF, USAN)
• RU 23908 (IS: RousselUclaf)
• Nilutamide (PH: Ph. Eur. 6, BP 2010)
• Nilutamidum (PH: Ph. Eur. 6)

Brand Names

• Anandron
  Aventis, Czech Republic; Aventis, Peru; Aventis, Serbia; EU-Pharma, Netherlands; Sanofi-Aventis, Australia; Sanofi-Aventis, Brazil; Sanofi-Aventis, Canada; Sanofi-Aventis, France; Sanofi-Aventis, Hungary; Sanofi-Aventis, Mexico; Sanofi-Aventis, Netherlands; Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal



• Nilandron
  Sanofi-Aventis, United States

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.